Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
| Date first appeared online | 01/03/2021 |
| DOI | 10.1016/s2213-8587(21)00019-x |
| Authors | Bain S. |
| Journal Name | The Lancet Diabetes & Endocrinology |
| Volume | 9 |
Documents
- von Herrath2021.pdf , Book, ©2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)